Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:45 pm Purchase | 13G | Entero Therapeutics Inc. ENTO | ARMISTICE CAPITAL LLC | 78,061 4.990% | 78,061 (New Position) | View |
| 2023-02-14 12:43 pm Purchase | 13G | Entero Therapeutics Inc. ENTO | ARMISTICE CAPITAL LLC | 740,405 9.990% | 740,405 (New Position) | View |
| 2021-02-10 09:54 am Purchase | 13D | Entero Therapeutics Inc. ENTO | Ross Edmund Burke Jr. | 3,096,571 5.890% | 249,137 (+8.75%) | View |
| 2020-08-11 4:05 pm Purchase | 13D | Entero Therapeutics Inc. ENTO | Ross Edmund Burke Jr. | 2,847,434 9.990% | 170,063 (+6.35%) | View |
| 2020-02-14 09:00 am Sale | 13G | Entero Therapeutics Inc. ENTO | LYTTON LAURENCE W | 0 0.000% | -867,693 (Position Closed) | View |
| 2020-01-29 2:03 pm Sale | 13D | Entero Therapeutics Inc. ENTO | Ross Edmund Burke Jr. | 2,677,371 9.990% | -663,184 (-19.85%) | View |